Document Detail

Control of uterine hyperactivity caused by prostaglandin with intravenous terbutaline: a case report.
MedLine Citation:
PMID:  8113646     Owner:  NLM     Status:  MEDLINE    
Prostaglandin E2 is beginning to be used more widely for the induction of labor in this country. The main concern with vaginal administration is the difficulty in stopping uterine hyperactivity. This report is a case where intravenous terbutaline was given as soon as hyperactivity and fetal heart rate deceleration were detected. Using this treatment, hyperactivity was controlled and the fetal heart rate returned to normal. Unfortunately, cesarean section was necessary for fetal distress which developed two and a half hours later when syntocinon was started intravenously to augment the labor.
Y Herabutya; P O-Prasertsawat
Related Documents :
18951216 - History of cesarean before 32 weeks' gestation and trial of labor: what is the risk of ...
17647096 - Primary cesarean deliveries prior to labor in the united states, 1979-2004.
9841946 - Outcome of post-term pregnancy: a matched-pair case-control study.
1988876 - C-reactive protein in normal pregnancy.
2063806 - Spontaneous decidual reactions and menstruation in the black mastiff bat, molossus ater.
22336906 - Maternal serum vitamin d levels at 11-13 weeks of gestation in preeclampsia.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of the Medical Association of Thailand = Chotmaihet thangphaet     Volume:  76 Suppl 1     ISSN:  0125-2208     ISO Abbreviation:  J Med Assoc Thai     Publication Date:  1993 Jan 
Date Detail:
Created Date:  1994-03-29     Completed Date:  1994-03-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7507216     Medline TA:  J Med Assoc Thai     Country:  THAILAND    
Other Details:
Languages:  eng     Pagination:  100-4     Citation Subset:  IM    
Department of Obstetrics & Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Dinoprostone / adverse effects*
Infusions, Intravenous
Labor, Induced
Terbutaline / administration & dosage*
Uterine Contraction / drug effects*
Reg. No./Substance:
23031-25-6/Terbutaline; 363-24-6/Dinoprostone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prolactin cell carcinoma of the pituitary.
Next Document:  Clinical applications of GnRH agonists in gynaecology.